Oral Answers to Questions

Liam Byrne Excerpts

Thursday 11th December 2025 Commons Chamber

[Mr Speaker]

I call the Chair of the Business and Trade Committee.

[Liam Byrne (Birmingham Hodge Hill and Solihull North) (Lab)]

May I welcome the deal with the United States to set zero tariffs on pharmaceutical exports? Together with the British Business Bank’s investment of £100 million in biotech, that is a real boost. However, the US offer was for just three years, whereas the price adjustment we have promised for the NHS is permanent. When the Secretary of State met the Secretary of Commerce and the United States Trade Representative in America last night, what assurance did he get that the Americans will not come back and reimpose tariffs on UK pharmaceuticals in three years’ time?

[Chris Bryant]

I completely agree with the Chair of the Business and Trade Committee; this is a really good deal in many ways, not least because, as somebody who has benefited from medical advances that have happened in the past few years—I received immunotherapy that had been licensed only a week before I went to the GP with my stage 3 melanoma in 2019—I know how important it is not only that the UK has a strong life sciences sector, but that people can access those drugs through the system in the UK. I think this is a good deal. I am afraid I cannot answer his precise question about what conversations the Secretary of State had last night, because I was having discussions with another country about another deal, which we might be able to announce very soon.